DNA aliquots from a consecutive subset (n = 100) of the 314 CRC samples were analysed for KRAS mutations in codons 12 and 13 using both methods, and interpreted according to the manuals regarding procedures and criteria for positive and negative mutation results. This evidence concerns the gene KRAS and colorectal carcinoma.